Cite
HARVARD Citation
Nakatani, D. et al. (n.d.). First‐in‐Man Study of the Low‐Dose Paclitaxel Using the COBRA‐P Drug‐Eluting Coronary Stent System With a Novel Biodegradable Coating in De Novo Coronary Lesions. Catheterization and cardiovascular interventions. 84 (7), pp. 1101-1109. [Online].